Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOMERICA INCBMRA · Entity 8171 | Director · Chief Executive Officer | August 26, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOMERICA INC
Report date August 26, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 242,570 |
Reported balance
After 2026-08-26 transaction · row 1
1 source rowRow 1 · 2026-08-26 · Purchase · Acquired 31,250 · Balance 242,570 F1: On August 26, 2026, the reporting person acquired 31,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 26, 2026, the reporting person acquired 31,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2026 Filed Aug 27, 2026 21:23 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon stock | 31,250 | $1.60 | $50,000.00 |
DisclosureSEC source: 0001493152-26-040443 · ownership.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,570 F1 · shares: On August 26, 2026, the reporting person acquired 31,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers. Read SEC document |
| December 12, 2025 Filed Dec 31, 2025 22:10 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantCommon stock | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-029842 · ownership.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,320 F1 · shares: Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest over 4 years at 25% on each anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:30 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantCommon stock | 250,000 | $0.31 | $77,500.00 |
DisclosureSEC source: 0001493152-24-050501 · ownership.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,270,560 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over 4 years at 25% on each anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 22:10 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon-qualified stock option · Derivative | 155,000 | Not disclosed Strike: $1.01 | Not disclosed |
DisclosureSEC source: 0001493152-23-044912 · ownership.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,000 Underlying: Common Stock · 155,000 shares Expires 2033-12-13 F1 · shares: Options granted to Mr. Irani as part of his Fiscal 2024 Board compensation package. F3 · price: Not Applicable F2 · derivative.exercise_date: 25% vesting on 12/013/2024, 25% on 12/13/2025, 25% on 12/13/2026, and 25% on 12/13/2027 Read SEC document |
| May 25, 2023 Filed May 26, 2023 16:23 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 200 | $1.55 | $310.00 |
DisclosureSEC source: 0001513162-23-000101 · primary_doc.xml · nonDerivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,020,560 F1 · kind: Open Market Purchase Read SEC document |
| May 24, 2023 Filed May 26, 2023 16:23 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 500 | $1.61 | $805.00 |
DisclosureSEC source: 0001513162-23-000101 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,020,360 F1 · kind: Open Market Purchase Read SEC document |
| May 12, 2023 Filed May 12, 2023 20:39 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 1,700 | $1.17 | $1,989.00 |
DisclosureSEC source: 0001513162-23-000092 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,019,860 F1 · kind: Open Market Purchase Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:06 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 500 | $1.27 | $635.00 |
DisclosureSEC source: 0001513162-23-000091 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,018,160 F1 · kind: Open Market Purchase Read SEC document |
| May 09, 2023 Filed May 10, 2023 21:28 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 300 | $1.39 | $417.00 |
DisclosureSEC source: 0001513162-23-000088 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,017,660 F1 · kind: Open Market Purchase Read SEC document |
| May 04, 2023 Filed May 5, 2023 18:38 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 1,000 | $1.36 | $1,360.00 |
DisclosureSEC source: 0001513162-23-000082 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,017,360 F1 · kind: Open Market Purchase Read SEC document |
| April 28, 2023 Filed May 1, 2023 13:15 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 1,800 | $1.34 | $2,412.00 |
DisclosureSEC source: 0001513162-23-000078 · primary_doc.xml · nonDerivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,017,360 F1 · kind: Open Market Purchase Read SEC document |
| April 27, 2023 Filed May 1, 2023 13:15 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 2,600 | $1.31 | $3,406.00 |
DisclosureSEC source: 0001513162-23-000078 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,017,360 F1 · kind: Open Market Purchase Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 12:55 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 7,000 | $1.26 | $8,820.00 |
DisclosureSEC source: 0001513162-23-000077 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,012,960 F1 · kind: Open Market Purchase Read SEC document |
| April 20, 2023 Filed Dec 11, 2023 22:23 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon-qualified stock option · Derivative | 105,000 | Not disclosed Strike: $1.67 | Not disclosed |
DisclosureSEC source: 0001493152-23-044441 · ownership.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2033-04-20 F1 · shares: Options granted to Mr. Irani in April 2023 as part of his fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. F3 · price: Not Applicable F2 · derivative.exercise_date: 25% vesting on 12/07/2023, 25% on 12/07/2024, 25% on 12/07/2025 and 25% on 12/07/2026 Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 17:16 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 1,800 | $2.85 | $5,130.00 |
DisclosureSEC source: 0001513162-23-000009 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005,960 F1 · kind: Open Market Purchase Read SEC document |
| January 24, 2023 Filed Jan 25, 2023 16:36 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 2,000 | $2.81 | $5,620.00 |
DisclosureSEC source: 0001513162-23-000008 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004,160 F1 · kind: Open Market Purchase Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 23:32 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon-qualified stock option · Derivative | 100,000 | Not disclosed Strike: $4.46 | Not disclosed |
DisclosureSEC source: 0001513162-21-000150 · primary_doc.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 733,616 Underlying: Common Stock · 100,000 shares Expires 2031-12-09 F2 · price: Not applicable F1 · derivative.exercise_date: 25% exercisable 12/9/2022, 25% per year exercisable there after. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 23:14 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon-qualified stock option · Derivative | 78,616 | Not disclosed Strike: $6.36 | Not disclosed |
DisclosureSEC source: 0001513162-20-000234 · primary_doc.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633,616 Underlying: Common Stock · 78,616 shares Expires 2030-12-10 F2 · price: Not applicable F1 · derivative.exercise_date: 25% exercisable 12/20/2021, 25% per year exercisable there after. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 00:30 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 78,431 | $2.85 | $223,528.35 |
DisclosureSEC source: 0001513162-20-000032 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,002,160 F1 · kind: Purchased through an S-3 registration statement filed 6/3/17, file #333-219130(Prospectus filed 12/4/17). Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 22:21 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon Qualified Stock Option · Derivative | 125,000 | Not disclosed Strike: $2.81 | Not disclosed |
DisclosureSEC source: 0001513162-19-000261 · primary_doc.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,000 Underlying: Common Stock · 125,000 shares Expires 2029-12-20 F2 · price: Not applicable. F1 · derivative.exercise_date: Vests one-quarter 12/20/20 and one-quarter on Dec 20 each year thereafter. Read SEC document |
| December 21, 2018 Filed Dec 22, 2018 00:35 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 600 | $2.04 | $1,224.00 |
DisclosureSEC source: 0001513162-18-000327 · primary_doc.xml · nonDerivative · entry 3 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 923,729 F1 · kind: Purchased through an S-3 registration statement filed 6/3/17, file #333-219130 (Prospectus filed 12/4/17) Read SEC document |
| December 21, 2018 Filed Dec 22, 2018 00:35 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 1,000 | $2.05 | $2,050.00 |
DisclosureSEC source: 0001513162-18-000327 · primary_doc.xml · nonDerivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 923,129 F1 · kind: Purchased through an S-3 registration statement filed 6/3/17, file #333-219130 (Prospectus filed 12/4/17) Read SEC document |
| December 21, 2018 Filed Dec 22, 2018 00:35 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 2,000 | $1.82 | $3,640.00 |
DisclosureSEC source: 0001513162-18-000327 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 922,129 F1 · kind: Purchased through an S-3 registration statement filed 6/3/17, file #333-219130 (Prospectus filed 12/4/17) Read SEC document |
| December 20, 2018 Filed Dec 20, 2018 20:35 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 400 | $2.45 | $980.00 |
DisclosureSEC source: 0001513162-18-000320 · primary_doc.xml · nonDerivative · entry 3 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,129 F1 · kind: Purchased through an S-3 registration statement filed 06/30/2017, file #333-219130. (Prospectus filed 12/04/2017) Read SEC document |
| December 20, 2018 Filed Dec 22, 2018 00:05 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon Qualified Stock Option · Derivative | 150,000 | Not disclosed Strike: $2.25 | Not disclosed |
DisclosureSEC source: 0001513162-18-000326 · primary_doc.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,000 Underlying: Common Stock · 150,000 shares Expires 2028-12-20 F2 · price: Not applicable F1 · derivative.exercise_date: Vests one quarter 12/20/2019 and one-quarter on Dec 20 each year thereafter. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 20:35 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 400 | $2.45 | $980.00 |
DisclosureSEC source: 0001513162-18-000320 · primary_doc.xml · nonDerivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,729 F1 · kind: Purchased through an S-3 registration statement filed 06/30/2017, file #333-219130. (Prospectus filed 12/04/2017) Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 20:35 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 400 | $2.47 | $988.00 |
DisclosureSEC source: 0001513162-18-000320 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,329 F1 · kind: Purchased through an S-3 registration statement filed 06/30/2017, file #333-219130. (Prospectus filed 12/04/2017) Read SEC document |
| December 07, 2018 Filed Dec 10, 2018 20:02 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 33,390 | $2.70 | $90,153.00 |
DisclosureSEC source: 0001513162-18-000307 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918,929 F1 · kind: Purchased through an S-3 registration statement filed 06/30/2017, file #333-219130. (Prospectus filed 12/04/2017) Read SEC document |
| May 23, 2018 Filed May 25, 2018 17:09 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherCommon Stock | 25,000 | $3.73 | $93,250.00 |
DisclosureSEC source: 0001513162-18-000139 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 885,539 F1 · kind: Purchased through an S-3 registration statement filed 06/30/2017, file #333-219130. (Prospectus filed 12/04/2017) Read SEC document |
| February 09, 2018 Filed Feb 9, 2018 21:16 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 500 | $3.83 | $1,915.00 |
DisclosureSEC source: 0001513162-18-000038 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 860,539 Read SEC document |
| February 02, 2018 Filed Feb 5, 2018 22:24 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 1,000 | $3.96 | $3,960.00 |
DisclosureSEC source: 0001513162-18-000037 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 860,039 Read SEC document |
| January 25, 2018 Filed Jan 25, 2018 23:13 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 1,200 | $4.03 | $4,830.00 |
DisclosureSEC source: 0001513162-18-000034 · primary_doc.xml · nonDerivative · entry 4 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 859,039 Read SEC document |
| January 25, 2018 Filed Jan 25, 2018 23:13 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 350 | $4.01 | $1,403.50 |
DisclosureSEC source: 0001513162-18-000034 · primary_doc.xml · nonDerivative · entry 3 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 857,839 Read SEC document |
| January 25, 2018 Filed Jan 25, 2018 23:13 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 489 | $4.04 | $1,975.56 |
DisclosureSEC source: 0001513162-18-000034 · primary_doc.xml · nonDerivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 857,489 Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 23:13 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 500 | $3.85 | $1,925.00 |
DisclosureSEC source: 0001513162-18-000034 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 857,000 Read SEC document |
| January 22, 2018 Filed Jan 25, 2018 00:27 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon qualified stock option · Derivative | 75,000 | Not disclosed Strike: $3.90 | Not disclosed |
DisclosureSEC source: 0001513162-18-000029 · primary_doc.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-22 F2 · price: Inapplicable. F1 · derivative.exercise_date: Vests one-third on 01/22/2019 and one-third on January 22nd each year thereafter. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 16:00 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherNon-qualified stock option · Derivative | 75,000 | Not disclosed Strike: $0.43 | Not disclosed |
DisclosureSEC source: 0001513162-16-001084 · primary_doc.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 75,000 shares Expires 2017-01-15 F1 · price: Consists of various options previously reported with varying dates expiring and prices exercisable Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 16:00 UTC | BIOMERICA INC BMRA · Entity 8171 | Exercise / conversionCommon Stock | 75,000 | $0.43 | $32,250.00 |
DisclosureSEC source: 0001513162-16-001084 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 856.5 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2016 Filed Dec 5, 2016 21:03 UTC Amendment | BIOMERICA INC BMRA · Entity 8171 | OtherNon-qualified stock option · Derivative | 75,000 | Not disclosed Strike: $0.43 | Not disclosed |
DisclosureSEC source: 0001513162-16-001089 · primary_doc.xml · derivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 75,000 shares Expires 2017-01-15 F2 · price: Consists of various options previously reported with varying dates expiring and prices exercisable Read SEC document |
| November 17, 2016 Filed Dec 5, 2016 21:03 UTC Amendment | BIOMERICA INC BMRA · Entity 8171 | Exercise / conversionCommon Stock | 75,000 | $0.43 | $32,250.00 |
DisclosureSEC source: 0001513162-16-001089 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 856,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: To correct transmission error in the total number of shares owned Read SEC document |
| November 14, 2016 Filed Nov 14, 2016 17:32 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 300 | $1.96 | $588.00 |
DisclosureSEC source: 0001513162-16-001081 · primary_doc.xml · nonDerivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,500 Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 17:32 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 100 | $1.89 | $189.00 |
DisclosureSEC source: 0001513162-16-001081 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,200 Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 19:28 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 100 | $1.70 | $170.00 |
DisclosureSEC source: 0001513162-16-001073 · primary_doc.xml · nonDerivative · entry 2 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,100 Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 19:28 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 400 | $1.75 | $700.00 |
DisclosureSEC source: 0001513162-16-001073 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781,000 Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:58 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 1,000 | $1.95 | $1,949.90 |
DisclosureSEC source: 0001513162-16-001069 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 780,600 Read SEC document |
| September 07, 2016 Filed Sep 9, 2016 21:25 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon Stock | 199 | $2.65 | $527.35 |
DisclosureSEC source: 0001513162-16-001001 · primary_doc.xml · nonDerivative · entry 1 Irani Zackary S. · CIK 0001282349 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779,600 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.